Aspirin as a cancer fighter? new trial targets colon cancer with PI3K mutation
NCT ID NCT02945033
First seen Feb 24, 2026 · Last updated May 07, 2026 · Updated 9 times
Summary
This study tests whether taking a low-dose aspirin daily after colon cancer surgery can lower the chance of the cancer returning. It is for patients whose tumors have a specific genetic change called PI3K mutation. The trial compares aspirin to a placebo (a pill with no medicine) to see which group has fewer recurrences or deaths.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rouen University Hospital
RECRUITINGRouen, France
Contact
Conditions
Explore the condition pages connected to this study.